Oramed Pharmaceuticals Inc.ORMPNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 75% recommend buying.

Consensus Rating

Buy

8 analysts·Limited coverage

75%

Rating Distribution

Strong Buy

00%

Buy

675%

Hold

225%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

No analyst price targets available for ORMP

Analyst coverage may not be available for this symbol

Earnings & Revenue Estimates

2026E$-1.26(1 analysts)

P/E3x

Current: 3.2x

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev—

EPS—

Earnings Surprises

Beat rate:67%(8/12 quarters)

Avg surprise:-367.8%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

No recent analyst actions

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance